NASDAQ:AVIR | Free Cash Flow | Atea Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$46.39M
2025-12-31-$28.22M
2025-03-31-$30.56M
2024-12-31-$30.4M
2024-03-31-$39.87M
2023-12-31-$21.83M
2023-03-31-$29.85M
2022-12-31-$21.55M$0.00-$21.55M
2022-03-31-$59.01M$44,000.00-$59.05M
2021-12-31-$75.42M
2021-03-31-$16.84M
2020-12-31$318.52M$5,000.00$318.52M1542.00%
2020-03-31-$4.51M
2019-12-31-$3.94M$0.00-$3.94M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$132.03M
2024-12-31-$135.5M
2023-12-31-$85.4M
2022-12-31-$120.98M$1.94M-$122.93M
2021-12-31-$87.01M$4,000.00-$87.01M-71.80%
2020-12-31$296.73M$26,000.00$296.71M
2019-12-31-$12.83M$2,000.00-$12.83M
2018-12-31-$7.91M$12,000.00-$7.92M